164 related articles for article (PubMed ID: 29045960)
21. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome.
Hao GX; Huang X; Zhang DF; Zheng Y; Shi HY; Li Y; Jacqz-Aigrain E; Zhao W
Br J Clin Pharmacol; 2018 Aug; 84(8):1748-1756. PubMed ID: 29637588
[TBL] [Abstract][Full Text] [Related]
22. A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients.
Herden U; Sterneck M; Buchholz BM; Achilles EG; Ott A; Fischer L
Immun Inflamm Dis; 2021 Dec; 9(4):1771-1780. PubMed ID: 34559956
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and Pharmacodynamics of Once-Daily Tacrolimus Compared With Twice-Daily Tacrolimus in the Early Stage After Living Donor Liver Transplantation.
Iwasaki M; Yano I; Fukatsu S; Hashi S; Yamamoto Y; Sugimoto M; Fukudo M; Masuda S; Nakagawa S; Yonezawa A; Kaido T; Uemoto S; Matsubara K
Ther Drug Monit; 2018 Dec; 40(6):675-681. PubMed ID: 29965882
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome
.
Wang X; Han Y; Chen C; Ma L; Xiao H; Zhou Y; Cui Y; Wang F; Su B; Yao Y; Ding J
Int J Clin Pharmacol Ther; 2019 Mar; 57(3):125-134. PubMed ID: 30663980
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
[TBL] [Abstract][Full Text] [Related]
26. A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trial.
Karaterzi S; Tönshoff B; Ahlenstiel-Grunow T; Baghai M; Beck B; Büscher A; Eifler L; Giese T; Lezius S; Müller C; Oh J; Zapf A; Weber LT; Pape L
Front Nephrol; 2024; 4():1331510. PubMed ID: 38444519
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic Profile of Twice- and Once-daily Tacrolimus in Pediatric Kidney Transplant Recipients.
Takahashi Y; Shishido S; Hyodo Y; Yonekura T; Nihei H; Itabashi Y; Muramatsu M; Hamasaki Y; Kawamura T; Aikawa A
Transplant Proc; 2017; 49(1):37-40. PubMed ID: 28104153
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy.
Ericzon BG; Varo E; Trunečka P; Fischer L; Colledan M; Gridelli B; Valdivieso A; O'Grady J; Dickinson J; Undre N
Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28295581
[TBL] [Abstract][Full Text] [Related]
29. Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients.
Buendía JA; Otamendi E; Kravetz MC; Cairo F; Ruf A; de Davila M; Powazniak Y; Nafissi J; Lazarowski A; Bramuglia G; Villamil F
Exp Clin Transplant; 2015 Oct; 13(5):441-8. PubMed ID: 26450467
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen.
Greanya ED; Poulin E; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Am J Health Syst Pharm; 2012 Jan; 69(2):134-42. PubMed ID: 22215359
[TBL] [Abstract][Full Text] [Related]
31. The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients.
Montini G; Ujka F; Varagnolo C; Ghio L; Ginevri F; Murer L; Thafam BS; Carasi C; Zacchello G; Plebani M
Pediatr Nephrol; 2006 May; 21(5):719-24. PubMed ID: 16550361
[TBL] [Abstract][Full Text] [Related]
32. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.
Moes DJ; van der Bent SA; Swen JJ; van der Straaten T; Inderson A; Olofsen E; Verspaget HW; Guchelaar HJ; den Hartigh J; van Hoek B
Eur J Clin Pharmacol; 2016 Feb; 72(2):163-74. PubMed ID: 26521259
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial.
Wlodarczyk Z; Ostrowski M; Mourad M; Krämer BK; Abramowicz D; Oppenheimer F; Miller D; Dickinson J; Undre N
Ther Drug Monit; 2012 Apr; 34(2):143-7. PubMed ID: 22406656
[TBL] [Abstract][Full Text] [Related]
35. Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.
Woillard JB; Debord J; Monchaud C; Saint-Marcoux F; Marquet P
Clin Pharmacokinet; 2017 Dec; 56(12):1491-1498. PubMed ID: 28389935
[TBL] [Abstract][Full Text] [Related]
36. Sublingual tacrolimus: a pharmacokinetic evaluation pilot study.
Tsapepas D; Saal S; Benkert S; Levine D; Delfin M; Cremers S; Amann S; Dadhania D; Kapur S; Aull M
Pharmacotherapy; 2013 Jan; 33(1):31-7. PubMed ID: 23307542
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients.
Garnock-Jones KP
Drugs; 2015 Feb; 75(3):309-20. PubMed ID: 25613762
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
Niioka T; Satoh S; Kagaya H; Numakura K; Inoue T; Saito M; Narita S; Tsuchiya N; Habuchi T; Miura M
Transplantation; 2012 Nov; 94(10):1013-9. PubMed ID: 23073468
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial.
Undre N; Baccarani U; Britz R; Popescu I
Ann Transplant; 2019 May; 24():268-272. PubMed ID: 31086126
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of mycophenolic acid in children with clinically stable idiopathic nephrotic syndrome receiving cyclosporine.
Hibino S; Nagai T; Yamakawa S; Ito H; Tanaka K; Uemura O
Clin Exp Nephrol; 2017 Feb; 21(1):152-158. PubMed ID: 27105859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
